SARS-CoV-2 Main Protease Active Site Ligands in the Human Metabolome
In late 2019, a global pandemic occurred. The causative agent was identified as a member of the <i>Coronaviridae</i> family, called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this study, we present an analysis on the substances identified in the human metabolome cap...
Main Authors: | Anna Maria Sardanelli, Camilla Isgrò, Luigi Leonardo Palese |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/5/1409 |
Similar Items
-
Systematic Search for SARS-CoV-2 Main Protease Inhibitors for Drug Repurposing: Ethacrynic Acid as a Potential Drug
by: Camilla Isgrò, et al.
Published: (2021-01-01) -
Prioritisation of Compounds for 3CL<sup>pro</sup> Inhibitor Development on SARS-CoV-2 Variants
by: Marko Jukič, et al.
Published: (2021-05-01) -
Ensemble Docking Coupled to Linear Interaction Energy Calculations for Identification of Coronavirus Main Protease (3CL<sup>pro</sup>) Non-Covalent Small-Molecule Inhibitors
by: Marko Jukič, et al.
Published: (2020-12-01) -
Development of a Cell-Based Luciferase Complementation Assay for Identification of SARS-CoV-2 3CL<sup>pro</sup> Inhibitors
by: Jonathan M.O. Rawson, et al.
Published: (2021-01-01) -
Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188
by: Gordon J. Lockbaum, et al.
Published: (2021-01-01)